Scientific and Clinical Impacts of UK Biobank in Cardiovascular Medicine

Circulation. 2024 Dec 10;150(24):1907-1909. doi: 10.1161/CIRCULATIONAHA.124.072449. Epub 2024 Dec 9.

Adam J Lewandowski^{1

2}, Martin K Rutter^{2

3

4}, Rory Collins^{1

2}

¹ Nuffield Department of Population Health, University of Oxford, UK (A.J.L., R.C.).
² UK Biobank Ltd, Stockport, Greater Manchester, UK (A.J.L., M.K.R., R.C.).
³ Division of Endocrinology, Diabetes & Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK (M.K.R.).
⁴ Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, UK (M.K.R.).

No abstract available

Keywords: UK Biobank; cardiometabolic risk factors; cardiovascular diseases; diabetes; hypertension; longitudinal studies; obesity.